What You Should Know:
– Fangzhou Inc., a leader in Internet healthcare solutions announced a strategic collaboration with Novo Nordisk, a leading global healthcare company.
– The Memorandum of Understanding (MOU) was signed at the 3rd…
Continue Reading
🎧 Subscribe to The Pulse by Wharton Digital Health on Apple, Spotify, Substack, or Twitter for more conversations with the leaders reshaping health tech.Obesity and weight loss are among the most significant and complex challenges…
Continue Reading
Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
